WANTAI SARS-CoV-2 IGRA - INF-Gamma

The WANTAI SARS-CoV-2 IGRA - INF-Gamma is a high-performance interferon-gamma release assay (IGRA) designed to detect T-cell-mediated immune responses specific to SARS-CoV-2. Unlike traditional antibody tests, this advanced in vitro diagnostic test measures the release of interferon-gamma (IFN-γ) by T-cells in response to SARS-CoV-2 antigens, providing a reliable evaluation of cellular immunity even in individuals with low or undetectable antibody levels. This assay is ideal for assessing long-term immune memory, evaluating post-vaccination immunity, or monitoring immune response in immunocompromised individuals. The test uses whole blood samples, is compatible with standard ELISA platforms, and delivers accurate, quantitative results with high sensitivity and specificity.